相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Strategies to genetically engineer T cells for cancer immunotherapy
Timothy T. Spear et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guerin
Ashish M. Kamat et al.
EUROPEAN UROLOGY (2016)
Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia
Iman Mansour et al.
HEMATOLOGY (2016)
IL-4 sensitivity shapes the peripheral CD8+ T cell pool and response to infection
Kristin R. Renkema et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Clinical significance of T-bet, GATA-3, and Bcl-6 transcription factor expression in bladder carcinoma
Islem Ben Bahria-Sediki et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
GATA3 immunohistochemical expression in invasive urothelial carcinoma
Kareem Hosny Mohammed et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical bacillus calmette-guerin therapy in bladder cancer
Renate Pichler et al.
ONCOTARGET (2016)
Ecto-ATPase CD39 Inactivates Isoprenoid-Derived Vγ9Vδ2 T Cell Phosphoantigens
Georg Gruenbacher et al.
CELL REPORTS (2016)
Serum tryptophan, kynurenine, phenylalanine, tyrosine and neopterin concentrations in 100 healthy blood donors
Simon Geisler et al.
PTERIDINES (2015)
Loss of GATA3 in bladder cancer promotes cell migration and invasion
Yi Li et al.
CANCER BIOLOGY & THERAPY (2014)
IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells
Terry-Ann Curran et al.
IMMUNOBIOLOGY (2014)
Simultaneous Inhibition of T Helper 2 and T Regulatory Cell Differentiation by Small Molecules Enhances Bacillus Calmette-Guerin Vaccine Efficacy against Tuberculosis
Debapriya Bhattacharya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Predicting response to bacillus Calmette-Guerin (BCG) in patients with carcinoma in situ of the bladder
Rafael Nunez-Nateras et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
CD161 Defines a Transcriptional and Functional Phenotype across Distinct Human T Cell Lineages
Joannah R. Fergusson et al.
CELL REPORTS (2014)
A Role for T-Lymphocytes in Human Breast Cancer and in Canine Mammary Tumors
Maria Isabel Carvalho et al.
BIOMED RESEARCH INTERNATIONAL (2014)
T-bet and Gata3 in controlling type 1 and type 2 immunity mediated by innate lymphoid cells
Thomas Hoyler et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Marko Babjuk et al.
EUROPEAN UROLOGY (2013)
Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells
You Jeong Lee et al.
NATURE IMMUNOLOGY (2013)
Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder
Hiroshi Miyamoto et al.
BJU INTERNATIONAL (2012)
Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma
H. Miyamoto et al.
CURRENT CANCER DRUG TARGETS (2012)
Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma
Qinghua Feng et al.
GYNECOLOGIC ONCOLOGY (2012)
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor
Hiroshi Miyamoto et al.
HUMAN PATHOLOGY (2012)
Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer
Claire Biot et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements
Aditi Kanhere et al.
NATURE COMMUNICATIONS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
Lucia De Monte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype
K. M. Dwyer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Neopterin, a prognostic marker in human malignancies
Robert Sucher et al.
CANCER LETTERS (2010)
Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after Bacillus Calmette-Guérin (BCG) immunotherapy
A. M. JACKSON et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Serum Th1 and Th2 cytokine balance in patients of superficial transitional cell carcinoma of bladder pre- and post-intravesical combination immunotherapy
Abhilasha Agarwal et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2010)
IDO Upregulates Regulatory T Cells via Tryptophan Catabolite and Suppresses Encephalitogenic T Cell Responses in Experimental Autoimmune Encephalomyelitis
Yaping Yan et al.
JOURNAL OF IMMUNOLOGY (2010)
How are TH1 and TH2 effector cells made?
Derk Amsen et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Dose-dependent synergy of Th1-stimulating cytokines on bacille Calmette-Guerin-induced interferon-γ production by human mononuclear cells
X. Chen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC:: implications for antitumor immune responses
Claudia Falkensammer et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Flow Cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of Superficial Transitional cell carcinoma of bladder
A Agarwal et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
BCG dose reduction by decreasing the instillation frequency: Effects on local Th1/Th2 cytokine responses in a mouse model
EC de Boer et al.
EUROPEAN UROLOGY (2005)
Dendritic cell maturation by innate lymphocytes:: coordinated stimulation of innate and adaptive immunity
C Münz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3
ES Hwang et al.
SCIENCE (2005)
Analysis of local T lymphocyte subsets upon stimulation with intravesical BCG: A model to study tuberculosis immunity
A Ponticiello et al.
RESPIRATORY MEDICINE (2004)
Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor microenvironment
A Loskog et al.
JOURNAL OF IMMUNOLOGY (2004)
Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation
H Suttmann et al.
JOURNAL OF UROLOGY (2004)
Polarisation of a T-helper cell immune response by activation of dendritic cells with CpG-containing oligonucleotides: a potential therapeutic regime for bladder cancer immunotherapy
H Atkins et al.
BRITISH JOURNAL OF CANCER (2003)
Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guerin response of superficial bladder cancer during induction course and maintenance therapy
F Saint et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guerin immunotherapy for carcinoma in situ of the bladder
E Watanabe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
The function role of GATA-3 in Th1 and Th2 differentiation
M Zhou et al.
IMMUNOLOGIC RESEARCH (2003)
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4+ T cell responses against MAGE-6 in HLA-DRB1*0401+ patients with renal cell carcinoma or melanoma
T Tatsumi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages
LH Carvalho et al.
NATURE MEDICINE (2002)
Local immunostimulation induced by intravesical administration of autologous interferon-gamma-activated macrophages in patients with superficial bladder cancer
F Pagès et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer
J Riemensberger et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guerin treatment
F Saint et al.
BJU INTERNATIONAL (2001)
Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8+ T cells
T Schüler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Activation of natural killer cells by bacillus Calmette-Guerin
S Brandau et al.
EUROPEAN UROLOGY (2001)
分享论文
